NAD+ in Regenerative Medicine: What the Human Data Show
Summarized from peer-reviewed systematic reviews, clinical trials, and regulatory disclosures — all based on human evidence.
Foundational Biology
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme that serves as a substrate for sirtuins and PARPs, playing essential roles in cellular energy metabolism, DNA repair, gene regulation, and mitochondrial function. NAD+ levels decline with age, a phenomenon linked to age-related conditions.
Review: NAD+ metabolism & signaling (PMC7333326)Human Clinical Trial Evidence
A 2026 PRISMA systematic review of 113 studies (33 human intervention trials) confirmed that oral NAD+ precursors — NR and NMN — consistently elevate blood and cellular NAD+ levels. NR is safe at doses up to 2,000 mg/day over 12 weeks. However, functional outcomes show significant heterogeneity.
2026 PRISMA systematic review (PMID 39847131)Safety Profile & Evidence Gaps
Common side effects: muscle pain, fatigue, headache, gastrointestinal symptoms — typically mild. A 2026 RCT (RENEWAL-NAD+, NCT07336836) reported a 53% intracellular NAD increase with 5 days of oral liposomal NAD+, with only one mild nausea event. Long-term safety data remain limited.
RENEWAL-NAD+ trial (NCT07336836)Primary Research Sources
All information on this page is drawn exclusively from the following peer-reviewed human studies and regulatory disclosures.
Referenced Studies
- NAD+ Metabolism Review (2020): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333326/ — Comprehensive review of NAD+ biology, bioenergetics, and therapeutic potential.
- 2026 PRISMA Systematic Review (PMID 39847131): https://pubmed.ncbi.nlm.nih.gov/39847131/ — Meta-analysis of 113 studies including 33 human intervention trials on NAD+ precursors.
- RENEWAL-NAD+ Clinical Trial (NCT07336836): https://clinicaltrials.gov/ct2/show/NCT07336836 — 2026 randomized controlled trial of oral liposomal NAD+ in humans.
These sources are provided for reference. Always consult a licensed physician for medical decisions.
Explanatory Overview: NAD+ & Regenerative Medicine
This informational guide provides a detailed summary of the evidence reviewed on this page, including:
- The biological role of NAD+ in cellular metabolism and DNA repair
- Summary of human clinical trial data on NR and NMN supplementation
- Documented safety profile and known side effects
- Current evidence gaps and expert consensus statements
- Regulatory status and important considerations
This guide is intended for educational purposes to help you make informed decisions in consultation with your physician.
Evidence Summary (PDF)
Download our research summary on NAD+ and regenerative medicine — based on the human studies referenced above.
Download SummaryClinical Perspective on NAD+ Research
NAD+ represents one of the most intensively studied molecular targets in aging and regenerative medicine. The foundational science is robust: NAD+ is essential for cellular energy, DNA repair, and the regulation of sirtuins and PARPs — enzymes that influence stem cell function and tissue homeostasis.
Human clinical trials have established that oral NAD+ precursors reliably elevate systemic NAD+ levels with a favorable short-term safety profile. However, the translation to measurable functional outcomes — improved physical performance, metabolic health, or tissue regeneration — remains inconsistent across studies. Heterogeneity in trial design, dosing, and outcome measures makes direct comparisons challenging.
Critically, no high-quality Phase III or IV trials have evaluated intravenous NAD+ for anti-aging or regenerative indications. Long-term safety data are limited, and validated biomarkers to correlate NAD+ levels with clinical endpoints do not yet exist. Expert consensus is clear: before any public health recommendations can be made, rigorous, well-controlled trials are urgently needed.
— Medical Director, Nexus Stem Cells
Begin Your Information Request
Take the next step toward understanding how regenerative medicine may support your health goals
Information Consultation
Request an informational consultation to discuss your health goals, review your medical history, and determine if our adjunctive framework is appropriate for your situation.
Educational Session
Request an educational session to learn more about our clinical framework, ask questions, and understand the theoretical basis for our supportive approaches.
Records Review
Submit your medical records for preliminary review by our medical team to determine if a full consultation would be beneficial for your specific situation.